Chances of Pregnancy Are Increasing
Our initial Essure pregnancy analysis in early 2013 suggested the pregnancy rate was 29% after reversal.
With more follow-up time we have seen the chance of pregnancy after reversal of Essure increased to 38%.
We attribute this increase in the observed pregnancy rate to two factors: restoration of natural fertility and improvement in operative techniques for Essure reversal.
Restoration of natural fertility. As is true with tubal ligation reversal, reversing Essure provides women an opportunity to become pregnant more than once. This is the main advantage of tubal reversal over a single cycle of IVF. The same is also true of Essure reversal. Women who have their coils removed and fallopian tube patency restored have the ability to become pregnant every month and more than once.
With the passage of time more women have the opportunity to become pregnant and with more time the actual success rates of Essure reversal become more evident.
Improved operative techniques. With a larger number of Essure reversal surgeries we have also been able to identify specific surgical techniques, which are more likely to result in pregnancy for our patients. These same techniques have increased the chance we can successfully remove the coils intact and minimize disruption of the blood supply to the fallopian tubes.
We are definitely seeing an increase in our ability to remove the coils intact, more precision in our tubal repair, and steady improvement in our Essure reversal pregnancy success rate.
IVF or Essure reversal
The chance of pregnancy after Essure reversal at our center is 38%. The chance of pregnancy after in-vitro fertilization (IVF) is approximately 37 % for each cycle attempted.
There is no data to suggest what the success rate of IVF is when the Essure coils are allowed to remain; however, several case reports do exist of successful IVF with Essure coils left in place.
If the Essure coils project into the uterine cavity this may decrease the success of IVF and may increase the risks of a pregnancy complications. Limited studies exist suggesting minimal risks to pregnancy in women who become pregnant after Essure failure or with IVF.
Recent studies suggest IVF may be less successful when the Essure devices are allowed to remain in the fallopian tubes during IVF treatment.
Cost of Essure reversal
Outpatient Essure reversal is more affordable than a single cycle of in-vitro fertilization. A single cycle of IVF costs approximately $12,000 to $14,000.
Even when you consider the cost of travel, lodging, and meals when having surgery at our center, Essure reversal can be more affordable then IVF. When you consider Essure reversal allows you the chance to have more than one child then Essure reversal becomes an even more affordable option if successful.
More information about Essure reversal
We understand the decision to have surgery is important. We are dedicated to providing you with as much information as possible to help you make the decision which is best for you.
If you decide to have surgery at our center, we want you to be comfortable with the knowledge you are traveling to have surgery with the best reversal team possible.
If you would like more information about Essure reversal or Essure removal at our center then we encourage you visit our For Physicians section of our website. For Physicians was created to provide referring health care providers with more medically detailed information about our unique practice.
For more medically detailed information about Essure removal visit: For Physicians
1. Normal pregnancy after outpatient tubouterine implantation in patient with Adiana sterilization
Monteith, Charles W. MD; Berger, Gary S. MD, MPH, Fertil Steril: July 2011 – Volume 98 – Issue Part 1 – pages e45-e46
2. Successful Pregnancies After Removal of Intratubal Microinserts
Monteith, Charles W. MD; Berger, Gary S. MD, MPH, Obstetrics & Gynecology: February 2012 – Volume 119 – Issue Part 2 – p 470–472
3. Pregnancy Success After Hysteroscopic Sterilization Reversal
Monteith, Charles W. MD; Berger, Gary S. MD; Zerden, Matthew L. MD, MPH, Obstetrics & Gynecology: December 2014 – Volume 124 – Issue 6 – p 1183–1189